​

Kodiak Sciences (KOD) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

KOD Stock Forecast

Kodiak Sciences (KOD) stock forecast, based on 18 Wall Street analysts, predicts a 12-month average price target of $64.67, with a high of $80.00 and a low of $56.00. This represents a 42.35% increase from the last price of $45.43.

- $16 $32 $48 $64 $80 High: $80 Avg: $64.67 Low: $56 Last Closed Price: $45.43

KOD Stock Rating

Kodiak Sciences stock's rating consensus is Buy, based on 18 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 12 Buy (66.67%), 5 Hold (27.78%), 1 Sell (5.56%), and 0 Strong Sell (0.00%).

Buy
Total 18 1 5 12 0 Strong Sell Sell Hold Buy Strong Buy

KOD Price Target Upside V Benchmarks

TypeNameUpside
StockKodiak Sciences42.35%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts-36
Avg Price Target-$64.67$49.83
Last Closing Price$45.43$45.43$45.43
Upside/Downside-42.35%9.69%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26151--7
Mar, 26151--7
Feb, 261511-8
Jan, 261421-8
Dec, 251421-8
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 27, 2026UBS$80.00$37.00116.22%76.10%
Jan 22, 2026Matthew CaufieldH.C. Wainwright$38.00$26.7142.27%-16.35%
Jan 07, 2026Michael YeeUBS$50.00$25.0599.60%10.06%
Sep 25, 2025Gena WangBarclays$17.00$15.499.75%-62.58%
Dec 09, 2024Michael YeeJefferies$20.00$11.4874.22%-55.98%
Sep 24, 2024Andrea TanGoldman Sachs$2.00$2.43-17.70%-95.60%
Nov 14, 2022Morgan Stanley$9.00$7.5918.58%-80.19%
Nov 10, 2022Goldman Sachs$8.00$7.2210.80%-82.39%
Aug 15, 2022Morgan Stanley$12.00$11.732.30%-73.59%
Aug 10, 2022Chardan Capital$18.00$11.8452.03%-60.38%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 27, 2026UBSBuyBuyhold
Jan 22, 2026H.C. WainwrightBuyBuyhold
Jan 07, 2026UBSNeutralBuyinitialise
Sep 22, 2025JefferiesBuyinitialise
Aug 14, 2025BarclaysUnderweightUnderweighthold
Sep 24, 2024Goldman SachsSellSellhold
Sep 05, 2024H.C. WainwrightNeutralinitialise
Apr 04, 2024UBSNeutralNeutralhold
Apr 01, 2024BarclaysUnderweightUnderweighthold
Jul 24, 2023Raymond JamesOutperforminitialise

Financial Forecast

EPS Forecast

Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-4.97$-3.35$-4.32---
Avg Forecast$-4.60$-3.39$-3.84$-3.72$-4.07$-2.73
High Forecast$-4.45$-3.24$-3.00$-3.72$-4.07$-2.73
Low Forecast$-4.70$-3.66$-4.39$-3.72$-4.07$-2.73
Surprise %8.04%-1.18%12.50%---

Revenue Forecast

$0 $30M $60M $90M $120M $150M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast-$62.02M$602.25K$11.32M$44.66M$138.13M
High Forecast-$62.02M$602.25K$11.32M$44.66M$138.13M
Low Forecast-$62.02M$602.25K$11.32M$44.66M$138.13M
Surprise %------

Net Income Forecast

$-300M $-260M $-220M $-180M $-140M $-100M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-260.49M$-176.21M$-229.97M---
Avg Forecast$-239.88M$-180.73M$-193.66M$-194.98M$-213.33M$-143.09M
High Forecast$-233.17M$-169.64M$-157.03M$-194.98M$-213.33M$-143.09M
Low Forecast$-246.59M$-191.81M$-230.28M$-194.98M$-213.33M$-143.09M
Surprise %8.59%-2.50%18.75%---

KOD Forecast FAQ

Is Kodiak Sciences stock a buy?

Kodiak Sciences stock has a consensus rating of Buy, based on 18 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 12 Buy, 5 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Kodiak Sciences is a favorable investment for most analysts.

What is Kodiak Sciences's price target?

Kodiak Sciences's price target, set by 18 Wall Street analysts, averages $64.67 over the next 12 months. The price target range spans from $56 at the low end to $80 at the high end, suggesting a potential 42.35% change from the previous closing price of $45.43.

How does Kodiak Sciences stock forecast compare to its benchmarks?

Kodiak Sciences's stock forecast shows a 42.35% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Kodiak Sciences over the past three months?

  • April 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 14.29% Strong Buy, 71.43% Buy, 14.29% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 12.50% Strong Buy, 62.50% Buy, 12.50% Hold, 12.50% Sell, 0% Strong Sell.

What is Kodiak Sciences’s EPS forecast?

Kodiak Sciences's average annual EPS forecast for its fiscal year ending in December 2026 is $-3.72, marking a -13.89% decrease from the reported $-4.32 in 2025. Estimates for the following years are $-4.07 in 2027, and $-2.73 in 2028.

What is Kodiak Sciences’s revenue forecast?

Kodiak Sciences's average annual revenue forecast for its fiscal year ending in December 2026 is $11.32M, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $44.66M, and $138.13M for 2028.

What is Kodiak Sciences’s net income forecast?

Kodiak Sciences's net income forecast for the fiscal year ending in December 2026 stands at $-195M, representing a -15.21% decrease from the reported $-230M in 2025. Projections indicate $-213M in 2027, and $-143M in 2028.